Global investment firm KKR has taken a commanding position in India’s healthcare sector by acquiring a majority stake in Healthcare Global Enterprises Limited (HCG). This move grants KKR sole control of the listed company, solidifying its presence in the country’s expanding medical services industry.
With the completion of the transaction, KKR-managed funds will emerge as the dominant shareholder in HCG. Dr. BS Ajaikumar, the company’s founder, will transition to the role of Non-Executive Chairman, focusing on enhancing clinical, academic, and research initiatives.
The acquisition entails the purchase of 51%-54% equity in HCG from CVC Asia V at ₹445 per share. Additionally, KKR has reached an agreement with HCG’s promoter family concerning their roles and commitments after the takeover. This acquisition also triggered an open offer under India’s Takeover Regulations.
A specialized advisory team played a crucial role in executing this high-profile deal, ensuring seamless due diligence across corporate, regulatory, real estate, and intellectual property matters. Strategic guidance, competition law assessments, and financial structuring were also integral to the process.
This acquisition marks a significant step in KKR’s expansion in India’s healthcare sector, positioning HCG for further growth and innovation under its new leadership structure.
